Examination of the relationship between antimicrobials and thrombocytosis;Association entre l'utilisation des antibiotiques et la thrombocytose

Annals of Pharmacotherapy

Volumn 46, Issue 10, 2012, Pages 1425-1429

  Forehand, Christy C ^a   Cribb, Jennifer ^b   Russell May, J ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antimicrobials; Thrombocytosis

Indexed keywords

ACICLOVIR; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; AZITHROMYCIN; AZTREONAM; CASPOFUNGIN; CEFOTAXIME; CEFPIROME; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANATE POTASSIUM PLUS TICARCILLIN; DAPSONE; FLUCONAZOLE; HALOPERIDOL; HEPARIN; LATAMOXEF; METRONIDAZOLE; MICONAZOLE; PENICILLIN G; PENTAMIDINE; PIPERACILLIN PLUS TAZOBACTAM; PREDNISOLONE; THALIDOMIDE; VORICONAZOLE; ZIDOVUDINE;

ANEMIA; ANTIMICROBIAL THERAPY; ARTICLE; ASTHMA; BLEEDING; CANDIDEMIA; COCCIDIOIDOMYCOSIS; COMMUNITY ACQUIRED PNEUMONIA; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; INFLAMMATION; LUNG INFECTION; PNEUMOCYSTIS PNEUMONIA; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SIDE EFFECT; SYSTEMATIC REVIEW; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOSIS;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; HUMANS; THROMBOCYTOSIS;

EID: 84867810734     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1R080     Document Type: Article

References (18)

1. Frye JL, Thompson DF. Drug-induced thrombocytosis. J Clin Pharm Ther 1993;18:45-8.
2. Schafer AI. Thrombocytosis and thrombocythemia. Blood Rev 2001;15: 159-66.
3. Aydogan T, Kanbay M, Alici O, Kosar A. Incidence and etiology of thrombocytosis in an adult Turkish population. Platelets 2006;17:328-31.
4. Vora AJ, Lilleyman JS. Secondary thrombocytosis. Arch Dis Child 1993; 68:88-90.
5. Schafer AI. Thrombocytosis. N Engl J Med 2004;350:1211-9.
6. Griesshammer M, Bangerter M, Sauer T, Wennauer R, Bergmann L, Heim-pel H. Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count. J Intern Med 1999;245:295-300.
7. Wiwanitkit V. Extreme thrombocytosis: what are the etiologies? Clin Appl Thromb Hemost 2006;12:85-7.
8. Moody SB, Pawlicki KS. Thrombocytosis and hyperkalemia associated with the use of ticarcillin/clavulanic acid. Drug Intell Clin Pharm 1987; 21:292-3.
9. Wynn RF, Laing RB, Leen CL. Case report of dapsone-related thrombo-cytosis in an AIDS patient. Am J Med 1995;98:602.
10. Finsterer J, Kotzailias N. Thrombocytosis under ciprofloxacin and tazobactam/piperacillin. Platelets 2003;14:329-31.
11. Yang CJ, Hwang JJ, Hung JY, Chong IW, Huang MS. Extreme thrombo-cytosis under the treatment by amoxicillin/clavulanate. Pharm World Sci 2006;28:326-8.
12. Chen HC, Wang CY, Wang CS. Marked thrombocytosis during treatment with ceftazidime for pulmonary infection. PharmWorld Sci 2008;30:70-2.
13. Marmion LC, Desser KB, Lilly RB, Stevens DA. Reversible thrombocy-tosis and anemia due to miconazole therapy. Antimicrob Agents Chemother 1976;10:447-9.
14. Saathoff AD, Elkins SL, Chapman SW, McAllister SF, Cleary JD. Thrombocytosis during antifungal therapy of candidemia. Ann Pharma-cother 2005;39:1238-43. doi: 10.1345/aph.1E402
15. Wolach B, Morag H, Drucker M, Sadan N. Thrombocytosis after pneu-monia with empyema and other bacterial infections in children. Pediatr Infect Dis J 1990;9:718-21.
16. Girgis NI, Butler T, Frenck RW, et al. Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrob Agents Chemother 1999;43:1441-4.
17. Parry MF, Jacobs B, Scully B, Neu HC. Thrombocytosis: an acute-phase reactant, not an adverse reaction to the new β-lactam antibiotics. Diagn Microbiol Infect Dis 1984;2:229-31.
18. Kilp T, Anttila M, Kallio MJ, Peltola H. Thrombocytosis and thrombocy-topenia in childhood bacterial meningitis. Pediatr Infect Dis J 1992;11: 456-60.